QA: TENAX THERAPEUTICS INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2021_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000034956')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 6,795,506
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,972
3 remainder_Assets 67,213
4 LiabilitiesCurrent 2,118,963
5 LiabilitiesNoncurrent 124,166
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,307,206
9 ResearchAndDevelopmentExpense 4,560,724
10 remainder_Expenses 1,627
11 remainder_Revenues 0
12 remainder_NetIncome 18,166
13 remainder_ComprehensiveNetIncome 19,703,310
  yvar yval
0 Assets 6,868,691
1 Liabilities 2,243,129
2 Expenses 9,869,557
3 Revenues 0
4 StockholdersEquity 4,625,562
5 NetIncome -9,851,391
6 ComprehensiveNetIncome 264
7 BaseVar 19,351,426
8 EconomicCapitalRatio 1.75

Edgar->Model Mapping

Feature Distribution

Change over Time